Crunchbase News
MAY 24, 2024
This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. So far in 2024, biotech and health companies have pulled in around $5.6 The biotech sector’s comparatively strong showing comes as overall Series A dealmaking looks on track to come in a bit above last year’s totals.
TechCrunch
NOVEMBER 16, 2022
Interestingly the model itself is not biotech-specific exactly but a derivative of the same “large language models” that have produced text production engines like GPT-3. ” Generate Biomedicines raises $370M Series B with a focus on protein-based drugs. Image Credits: Cradle.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
FEBRUARY 28, 2023
” Going private: A guide to PE tech acquisitions Biotech proved a surprisingly bright spot in 2022’s startup correction Image Credits: Getty Images The hard science and regulations that govern biotech companies sets them far apart from other startups. biotech deals also set new records in 2022 for both median deal size, $33.5
TechCrunch
SEPTEMBER 14, 2023
Proteins, the natural molecules that carry out key cellular functions within the body, are the building blocks of all diseases. Characterizing proteins can reveal the mechanisms of a disease, including ways to slow it or potentially reverse it, while creating proteins can lead to entirely new classes of drugs and therapeutics.
CIO
APRIL 17, 2024
The retail industry has no shortage of cases on display where generative AI has shown tangible benefits. They had ChatGPT write the script, and other gen AI tools to create a digital person who reads the script, a scalable process with at least one measurable benefit: speed. And software code is a language.”
CIO
MAY 15, 2024
Today we worry this phenomenon is playing out with enterprise adoption of generative AI. Generative AI (genAI) arrived on the scene with use cases such as “support chatbots” or “talk to your documentation apps” that were so obviously useful that many companies are well on their way to taking them into production.
Crunchbase News
MAY 31, 2024
xAI , $6B, artificial intelligence: Elon Musk ’s generative AI startup, xAI, officially announced its long-awaited fundraise — making it the second-most-valuable generative AI company in the world behind only competitor OpenAI. among others. among others. The xAI round had been rumored for months. just earlier this year.
Expert insights. Personalized for you.
116 
Let's personalize your content